Luxury Steakhouse Chain 801 Chophouse Files for Chapter 11 as Soaring Beef Prices Devastate the Restaurant Industry

A high-end steakhouse chain has become the latest casualty of skyrocketing beef costs and shifting consumer habits. 801 Restaurant Group LLC, the owner of the luxury steakhouse chain 801 Chophouse, has filed for Chapter 11 bankruptcy protection in a bid to restructure its mounting debts and keep its doors open. The petition was filed on April 10, 2026, in the U.S. Bankruptcy Court for the District of Kansas, listing both assets and liabilities in the range of $10 million to $50 million【1†L1-L5】【2†L5-L8】.

The bankruptcy filing highlights a perfect storm hammering the American dining landscape. For everyday consumers, the pain is showing up at both the supermarket checkout and the restaurant table. According to new data from the Federal Reserve Bank of St. Louis, beef prices have surged dramatically. In March 2026 alone, steak prices jumped 16% to an average of $12.73 per pound, while ground beef hit $6.70 per pound. Just five years ago, ground beef cost only $3.96 per pound, illustrating a staggering increase that is forcing families to rethink their grocery budgets【3†L1-L4】.

The root cause of this crisis is a dramatic supply shortage. The U.S. Department of Agriculture (USDA) reports that the nation’s beef cattle herd has shrunk to a 75-year low, with the total cattle and calf count falling to 86.2 million head【4†L1-L3】. This historic decline in supply is driving prices through the roof, and as prices climb, consumer demand inevitably slides, leaving restaurants trapped between high costs and falling sales.

801 Chophouse is just the most recent high-profile name to buckle under these pressures. The chain, known for its opulent dining experience, operates eight locations across the heartland, including in Denver, Des Moines, Kansas City, Leawood (Kan.), Minneapolis, Omaha, St. Louis, and Tysons Corner (Va.)【2†L7-L10】. The company has already been forced to shutter an affiliate, 801 Nicollet in Minneapolis, which previously operated as 801 Fish, signaling ongoing financial distress before the bankruptcy filing.

The menu prices at 801 Chophouse are a window into the economics of luxury dining during inflation. Despite the chain’s reputation for serving aged USDA prime cuts, Japanese Wagyu, and an award-winning wine list, the price tags are steep even for affluent diners. Current menu items include a Rosewood Ranches American ribeye for $145, a dry-aged porterhouse for $143, a 16-ounce wet-aged bone-in filet for $130, and a 12-ounce filet mignon for $87【5†L1-L3】. When the raw ingredient cost of beef jumps 16%, these already premium prices become even harder to justify, pushing customers to seek more affordable options.

Notably, 801 Chophouse is not alone in this struggle. Several large steakhouse chains have been forced to close dozens of locations just to stay afloat without needing bankruptcy protection. Bloomin’ Brands, the parent company of Outback Steakhouse, announced in 2025 that it would close 41 underperforming locations. More recently, the company confirmed it will shut its Fleming’s Prime Steakhouse in Houston’s Upper Kirby district on April 18, 2026, after a 25-year run, simply choosing not to renew the lease【6†L1-L5】.

Similarly, the once-mighty steak and seafood chain McCormick & Schmick’s, owned by Landry’s Inc., has been decimated. Once boasting 60 restaurants, the chain saw its count plummet to just 13 locations by the end of 2025 as sales declined by over 10% in a single year【7†L1-L4】.

For now, 801 Chophouse intends to continue operating its remaining restaurants while it navigates the bankruptcy process. The company, represented by Brown & Ruprecht PC, has not stated a specific reason for the filing beyond the economic pressures affecting the entire sector【2†L1-L4】. However, for steak lovers and industry watchers, the message is clear: The era of cheap beef is over, and the luxury dining sector is being forced to evolve or disappear.

🚨 MASSIVE EYE DROP RECALL – 3.1 MILLION bottles sold at CVS, Walgreens, Kroger may be UNSAFE. Bacteria risk = possible vision loss. Check your cabinet NOW. Lot numbers inside ⬇️

If you bought eye drops from CVS, Walgreens, or Kroger in the past year, check your medicine cabinet right now.

A California company called K.C. Pharmaceuticals just recalled more than 3.1 million bottles of lubricating eye drops. Why? Because they never properly tested whether the products were sterile. That means bacteria or fungus could be living inside those drops.

The recall started on March 3, 2026. But the affected bottles have expiration dates ranging from April 30, 2026 to October 31, 2026 – meaning you might have bought them as early as last April.

FDA recall notice for K.C. Pharmaceuticals eye drops

Report symptoms to the FDA

2023 eye drop outbreak information

What’s the real danger?

I’m a clinical pharmacologist and pharmacist who has studied drug safety for years. Here’s the truth: your eyes are terrible at fighting infections. Your immune system has a hard time reaching the eyeball, so if bacteria get in through dirty eye drops, an infection can turn severe fast – sometimes leading to vision loss.

Which products are recalled?

Eight different eye drop products are on the list. They’re sold under common store brands you see every day, including:

• Top Care, Best Choice, Good Sense, Rugby, Leader
• Good Neighbor Pharmacy, Quality Choice, Valu Merchandisers, Geri Care
• Walgreens, CVS, and Kroger store brands

The product names include:

• Dry Eye Relief Eye Drops
• Artificial Tears Sterile Lubricant Eye Drops
• Sterile Eye Drops Original Formula
• Sterile Eye Drops Redness Lubricant
• Eye Drops Advanced Relief
• Ultra Lubricating Eye Drops
• Sterile Eye Drops AC
• Sterile Eye Drops Soothing Tears

These were sold at Walgreens, CVS, Rite Aid, Kroger, Harris Teeter, Dollar General, Circle K, and Publix.

How to check if your drops are recalled
Go to the FDA website and look at the table. Match the product name and the lot number on your bottle. For example, recalled “Sterile Eye Drops AC” have lot number AC24E01 with expiration May 31, 2026.

• ✅ If your lot number or expiration date is different, you’re safe.
• ❌ If it matches, stop using the drops immediately. Return them to the store for a full refund.

No infections reported yet – but watch for these symptoms
As of early April 2026, the FDA hasn’t received any infection reports. But if you’ve used recalled drops and notice:

• Redness or pain in your eyes
• Eyelids stuck together in the morning
• Unusual discharge (goo or pus)
• Blurry vision or swelling
• Itchiness that won’t go away

…you could have an eye infection. See a doctor right away, and report your symptoms to the FDA.

This isn’t the first time
Back in 2023, a drug-resistant bacteria outbreak linked to contaminated eye drops infected 81 people across 18 states. Fourteen people lost vision, four had eyeballs removed, and four died.

Later that year, the FDA inspected K.C. Pharmaceuticals and issued a warning letter. The agency found the company failed to follow basic procedures to prevent contamination. Employees were reportedly barefoot on the manufacturing floor in some related cases (at a different company, Kilitch Healthcare). But K.C. didn’t fix its problems – and now, three years later, we have this massive recall.

Bottom line for Americans
If you’ve bought eye drops since April 2025, check the bottle. Don’t gamble with your eyesight. Return any recalled product and ask your pharmacist for a sterile alternative.

Rebecca King Crews Beats Tremors After Breakthrough Procedure – “I Can Write My Name Again”

USA PEOPLE – For nearly a decade, Rebecca King Crews – wife of Hollywood star Terry Crews – struggled with a mystery. Doctors kept telling her the shaking hands and numb foot were just anxiety. But she knew something was deeply wrong.

Now, at 60 years old, she’s finally sharing the truth: Rebecca has Parkinson’s disease. And in an exclusive interview with the TODAY show, she revealed a stunning comeback thanks to a brand-new, non-surgical procedure approved by the FDA just last year.

“I feel good. I’m able to write my name and my dates, and I’m able to write with my right hand for the first time in probably three years.” – Rebecca King Crews

Her nightmare began back in 2012 with numbness in her left foot during a workout. That turned into a limp. Then her trainer noticed her left arm wasn’t swinging right. One morning, while putting on lip gloss, she saw her hand shaking.

“My grandmother had tremors –Terry Crews knew exactly what that was,” Rebecca says.

But her primary doctor? He blamed over-exercising and anxiety. Even a neurologist was stumped. It took three long years and a Parkinson’s specialist to finally give her the real diagnosis in 2015.

The hardest part wasn’t the diagnosis – it was the daily humiliation. Tremors made it nearly impossible to brush her teeth, put on makeup, or even write a check.

But Rebecca refused to stop. While still searching for answers, she was writing a book, recording an album, and launching a clothing line. Her motto?

“Just keep walking. You don’t lay down and die because you got a diagnosis.”

That fighting spirit led her to a game-changing treatment: Bilateral Focused Ultrasound – a non-invasive procedure using MRI-guided sound waves to zap the exact brain areas causing movement problems. Unlike deep brain stimulation, there’s no incision, no implant, and recovery is fast.

The device, called Exablate Neuro from Insightec, was approved for one side of the brain in 2021. But last July, the FDA expanded approval to both sides – a huge leap for advanced Parkinson’s patients.

Rebecca had the procedure on March 4. The results were immediate.

• Right-hand tremor? Gone.
• Balance? Dramatically improved.
• Walking? Feels normal again.

She’s already cut back on medication. The only catch? Her left side symptoms remain – so she’s going back this September to get the left side treated.

When her husband Terry saw her write her own name for the first time in three years, he got choked up.

“She’s a superhero. She’s the rock of our lives. When they say ‘sickness and health,’ this is the battle we were designed to fight together.”

This isn’t the first health war Rebecca has won. In 2020, she had a double mastectomy after a breast cancer diagnosis. Through it all, Terry says they’ve built each other up for nearly 37 years.

Today, Rebecca still drives, plays piano, and attends acting class. She’s not waiting for a cure – she’s living fully right now. But she went public for a reason: to give others hope.

“I wanted to potentially make it more available to others, because it’s an expensive surgery, it’s not covered by insurance yet. And to give hope to people with Parkinson’s – I believe we’re going to find the cure.”

Terry echoes that optimism:

“We feel hopeful. We really feel like we are on the edge of a cure for Parkinson’s. We felt like we had to share this with the world.”

Terry Crews For millions of Americans living with Parkinson’s – or watching a loved one struggle – Rebecca’s story is more than a celebrity headline. It’s a real, tangible reason to believe that better days are coming.